作者
Michela Borghesan, Caterina Fusilli, Francesca Rappa, Concetta Panebianco, Giovanni Rizzo, Jude A Oben, Gianluigi Mazzoccoli, Chris Faulkes, Illar Pata, Antonella Agodi, Farhad Rezaee, Shane Minogue, Alessandra Warren, Abigail Peterson, John M Sedivy, Julien Douet, Marcus Buschbeck, Francesco Cappello, Tommaso Mazza, Valerio Pazienza, Manlio Vinciguerra
发表日期
2016/2/1
期刊
Cancer research
卷号
76
期号
3
页码范围
594-606
出版商
American Association for Cancer Research
简介
Aging is a major risk factor for progression of liver diseases to hepatocellular carcinoma (HCC). Cellular senescence contributes to age-related tissue dysfunction, but the epigenetic basis underlying drug-induced senescence remains unclear. macroH2A1, a variant of histone H2A, is a marker of senescence-associated heterochromatic foci that synergizes with DNA methylation to silence tumor-suppressor genes in human fibroblasts. In this study, we investigated the relationship between macroH2A1 splice variants, macroH2A1.1 and macroH2A1.2, and liver carcinogenesis. We found that protein levels of both macroH2A1 isoforms were increased in the livers of very elderly rodents and humans, and were robust immunohistochemical markers of human cirrhosis and HCC. In response to the chemotherapeutic and DNA-demethylating agent 5-aza-deoxycytidine (5-aza-dC), transgenic expression of macroH2A1 …
引用总数
20162017201820192020202120222023461191220106